The Fund Grade · free · no account needed
What grade does FMFEX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Fidelity Select Materials Portfolio
#383 of 500 graded active funds · blend · mid segment peer group
The point · specialist footprint
FMFEX puts less of its book behind proven specialists than 92% of graded funds.
● Bottom 20%
Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
FMFEX vs the Honor Roll · share card ↗Conviction exposure
0.8%
of the book in specialist-converged names
Late-stage weight
16%
of the book in Crowded or Fading names
Active share
97.5%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
FMFEX grades a D, ranking 383 out of 500 funds, so the overall picture is weak. Specialists are actively leaving CTVA, ALB, MLM, and AA, which together make up over 11% of the fund. The one bright spot is LIN at 16.3% of the portfolio, where proven specialists are still building early conviction.
→ Watch CTVA and ALB closely, as specialist exits from both positions suggest the thesis behind them is deteriorating.
→ Compare FMFEX against the three higher-graded peers in this segment, including options within the same Fidelity family.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.